Journal article icon

Journal article

Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with Venous Thromboembolism: Results of a randomized trial (SELECT-D)

Abstract:
Purpose Venous thromboembolism (VTE) is common in patients with cancer. Long-term daily subcutaneous low molecular weight heparin has been standard treatment for such patients. The purpose of this study was to assess if an oral factor Xa inhibitor, rivaroxaban, would offer an alternative treatment for VTE in patients with cancer. Patient and Methods In this multicenter, randomized, open-label, pilot trial in the United Kingdom, patients with active can... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's Version

Actions


Access Document


Files:
Publisher copy:
10.1200/jco.2018.78.8034

Authors


Marshall, A More by this author
Thirlwall, J More by this author
Chapman, O More by this author
Expand authors...
Publisher:
American Society of Clinical Oncology Publisher's website
Journal:
Journal of Clinical Oncology Journal website
Volume:
36
Issue:
20
Pages:
2017-2023
Publication date:
2018-05-10
DOI:
EISSN:
1527-7755
ISSN:
0732-183X
Pubs id:
pubs:862757
URN:
uri:d90c1698-c095-49d2-9c7a-5ade3a5404f3
UUID:
uuid:d90c1698-c095-49d2-9c7a-5ade3a5404f3
Local pid:
pubs:862757
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP